nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Confusional state—Pamidronate—osteoporosis	0.00072	0.00074	CcSEcCtD
Naratriptan—Vertigo—Zoledronate—osteoporosis	0.000718	0.000738	CcSEcCtD
Naratriptan—Syncope—Zoledronate—osteoporosis	0.000717	0.000736	CcSEcCtD
Naratriptan—Anaphylactic shock—Pamidronate—osteoporosis	0.000714	0.000733	CcSEcCtD
Naratriptan—Oedema—Pamidronate—osteoporosis	0.000714	0.000733	CcSEcCtD
Naratriptan—Haemoglobin—Estradiol—osteoporosis	0.000711	0.00073	CcSEcCtD
Naratriptan—Infection—Pamidronate—osteoporosis	0.000709	0.000729	CcSEcCtD
Naratriptan—Urticaria—Calcitriol—osteoporosis	0.000709	0.000728	CcSEcCtD
Naratriptan—Haemorrhage—Estradiol—osteoporosis	0.000707	0.000727	CcSEcCtD
Naratriptan—Palpitations—Zoledronate—osteoporosis	0.000706	0.000725	CcSEcCtD
Naratriptan—Body temperature increased—Calcitriol—osteoporosis	0.000705	0.000724	CcSEcCtD
Naratriptan—Hypoaesthesia—Estradiol—osteoporosis	0.000704	0.000723	CcSEcCtD
Naratriptan—Shock—Pamidronate—osteoporosis	0.000703	0.000722	CcSEcCtD
Naratriptan—Loss of consciousness—Zoledronate—osteoporosis	0.000702	0.000721	CcSEcCtD
Naratriptan—Hypersensitivity—Estropipate—osteoporosis	0.0007	0.000719	CcSEcCtD
Naratriptan—Nervous system disorder—Pamidronate—osteoporosis	0.0007	0.000719	CcSEcCtD
Naratriptan—Thrombocytopenia—Pamidronate—osteoporosis	0.000699	0.000718	CcSEcCtD
Naratriptan—Vomiting—Etidronic acid—osteoporosis	0.000699	0.000718	CcSEcCtD
Naratriptan—Cough—Zoledronate—osteoporosis	0.000697	0.000716	CcSEcCtD
Naratriptan—Rash—Etidronic acid—osteoporosis	0.000693	0.000712	CcSEcCtD
Naratriptan—Convulsion—Zoledronate—osteoporosis	0.000692	0.000711	CcSEcCtD
Naratriptan—Dermatitis—Etidronic acid—osteoporosis	0.000692	0.000711	CcSEcCtD
Naratriptan—Vertigo—Conjugated Estrogens—osteoporosis	0.000691	0.00071	CcSEcCtD
Naratriptan—Hyperhidrosis—Pamidronate—osteoporosis	0.00069	0.000709	CcSEcCtD
Naratriptan—Syncope—Conjugated Estrogens—osteoporosis	0.00069	0.000709	CcSEcCtD
Naratriptan—Hypersensitivity—Alendronate—osteoporosis	0.00069	0.000708	CcSEcCtD
Naratriptan—Headache—Etidronic acid—osteoporosis	0.000688	0.000707	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000684	0.000703	CcSEcCtD
Naratriptan—Asthenia—Estropipate—osteoporosis	0.000682	0.0007	CcSEcCtD
Naratriptan—Myalgia—Zoledronate—osteoporosis	0.00068	0.000699	CcSEcCtD
Naratriptan—Arthralgia—Zoledronate—osteoporosis	0.00068	0.000699	CcSEcCtD
Naratriptan—Palpitations—Conjugated Estrogens—osteoporosis	0.00068	0.000698	CcSEcCtD
Naratriptan—Anxiety—Zoledronate—osteoporosis	0.000678	0.000696	CcSEcCtD
Naratriptan—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000676	0.000695	CcSEcCtD
Naratriptan—Paraesthesia—Risedronate—osteoporosis	0.000674	0.000693	CcSEcCtD
Naratriptan—Pruritus—Estropipate—osteoporosis	0.000672	0.000691	CcSEcCtD
Naratriptan—Discomfort—Zoledronate—osteoporosis	0.000672	0.00069	CcSEcCtD
Naratriptan—Asthenia—Alendronate—osteoporosis	0.000672	0.00069	CcSEcCtD
Naratriptan—Hypersensitivity—Ibandronate—osteoporosis	0.000672	0.00069	CcSEcCtD
Naratriptan—Cough—Conjugated Estrogens—osteoporosis	0.000672	0.00069	CcSEcCtD
Naratriptan—Dyspnoea—Risedronate—osteoporosis	0.00067	0.000688	CcSEcCtD
Naratriptan—Hypotension—Pamidronate—osteoporosis	0.000667	0.000685	CcSEcCtD
Naratriptan—Convulsion—Conjugated Estrogens—osteoporosis	0.000667	0.000685	CcSEcCtD
Naratriptan—Dry mouth—Zoledronate—osteoporosis	0.000665	0.000683	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000665	0.000683	CcSEcCtD
Naratriptan—Fatigue—Ethinyl Estradiol—osteoporosis	0.000664	0.000682	CcSEcCtD
Naratriptan—Pruritus—Alendronate—osteoporosis	0.000662	0.00068	CcSEcCtD
Naratriptan—Tinnitus—Estradiol—osteoporosis	0.00066	0.000678	CcSEcCtD
Naratriptan—Constipation—Ethinyl Estradiol—osteoporosis	0.000659	0.000677	CcSEcCtD
Naratriptan—Confusional state—Zoledronate—osteoporosis	0.000658	0.000676	CcSEcCtD
Naratriptan—Hypersensitivity—Calcitriol—osteoporosis	0.000657	0.000675	CcSEcCtD
Naratriptan—Cardiac disorder—Estradiol—osteoporosis	0.000657	0.000674	CcSEcCtD
Naratriptan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000655	0.000673	CcSEcCtD
Naratriptan—Myalgia—Conjugated Estrogens—osteoporosis	0.000655	0.000673	CcSEcCtD
Naratriptan—Asthenia—Ibandronate—osteoporosis	0.000654	0.000672	CcSEcCtD
Naratriptan—Anxiety—Conjugated Estrogens—osteoporosis	0.000653	0.000671	CcSEcCtD
Naratriptan—Nausea—Etidronic acid—osteoporosis	0.000653	0.00067	CcSEcCtD
Naratriptan—Anaphylactic shock—Zoledronate—osteoporosis	0.000652	0.00067	CcSEcCtD
Naratriptan—Oedema—Zoledronate—osteoporosis	0.000652	0.00067	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000651	0.000668	CcSEcCtD
Naratriptan—Diarrhoea—Estropipate—osteoporosis	0.00065	0.000668	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000648	0.000666	CcSEcCtD
Naratriptan—Infection—Zoledronate—osteoporosis	0.000648	0.000666	CcSEcCtD
Naratriptan—Fatigue—Risedronate—osteoporosis	0.000648	0.000665	CcSEcCtD
Naratriptan—Pruritus—Ibandronate—osteoporosis	0.000645	0.000662	CcSEcCtD
Naratriptan—Constipation—Risedronate—osteoporosis	0.000642	0.00066	CcSEcCtD
Naratriptan—Pain—Risedronate—osteoporosis	0.000642	0.00066	CcSEcCtD
Naratriptan—Angiopathy—Estradiol—osteoporosis	0.000642	0.000659	CcSEcCtD
Naratriptan—Shock—Zoledronate—osteoporosis	0.000642	0.000659	CcSEcCtD
Naratriptan—Paraesthesia—Pamidronate—osteoporosis	0.000641	0.000659	CcSEcCtD
Naratriptan—Diarrhoea—Alendronate—osteoporosis	0.000641	0.000658	CcSEcCtD
Naratriptan—Asthenia—Calcitriol—osteoporosis	0.00064	0.000658	CcSEcCtD
Naratriptan—Nervous system disorder—Zoledronate—osteoporosis	0.00064	0.000657	CcSEcCtD
Naratriptan—Immune system disorder—Estradiol—osteoporosis	0.000639	0.000656	CcSEcCtD
Naratriptan—Thrombocytopenia—Zoledronate—osteoporosis	0.000639	0.000656	CcSEcCtD
Naratriptan—Dyspnoea—Pamidronate—osteoporosis	0.000637	0.000654	CcSEcCtD
Naratriptan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000635	0.000652	CcSEcCtD
Naratriptan—Chills—Estradiol—osteoporosis	0.000635	0.000652	CcSEcCtD
Naratriptan—Somnolence—Pamidronate—osteoporosis	0.000635	0.000652	CcSEcCtD
Naratriptan—Skin disorder—Zoledronate—osteoporosis	0.000634	0.000651	CcSEcCtD
Naratriptan—Pruritus—Calcitriol—osteoporosis	0.000631	0.000648	CcSEcCtD
Naratriptan—Hyperhidrosis—Zoledronate—osteoporosis	0.000631	0.000648	CcSEcCtD
Naratriptan—Diarrhoea—Raloxifene—osteoporosis	0.00063	0.000647	CcSEcCtD
Naratriptan—Dizziness—Estropipate—osteoporosis	0.000629	0.000646	CcSEcCtD
Naratriptan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000628	0.000645	CcSEcCtD
Naratriptan—Oedema—Conjugated Estrogens—osteoporosis	0.000628	0.000645	CcSEcCtD
Naratriptan—Alopecia—Estradiol—osteoporosis	0.000625	0.000642	CcSEcCtD
Naratriptan—Infection—Conjugated Estrogens—osteoporosis	0.000624	0.000641	CcSEcCtD
Naratriptan—Diarrhoea—Ibandronate—osteoporosis	0.000624	0.000641	CcSEcCtD
Naratriptan—Dizziness—Alendronate—osteoporosis	0.000619	0.000636	CcSEcCtD
Naratriptan—Shock—Conjugated Estrogens—osteoporosis	0.000618	0.000635	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000616	0.000633	CcSEcCtD
Naratriptan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000616	0.000633	CcSEcCtD
Naratriptan—Erythema—Estradiol—osteoporosis	0.000616	0.000633	CcSEcCtD
Naratriptan—Fatigue—Pamidronate—osteoporosis	0.000616	0.000632	CcSEcCtD
Naratriptan—Urticaria—Ethinyl Estradiol—osteoporosis	0.000612	0.000629	CcSEcCtD
Naratriptan—Pain—Pamidronate—osteoporosis	0.000611	0.000627	CcSEcCtD
Naratriptan—Constipation—Pamidronate—osteoporosis	0.000611	0.000627	CcSEcCtD
Naratriptan—Diarrhoea—Calcitriol—osteoporosis	0.00061	0.000627	CcSEcCtD
Naratriptan—Skin disorder—Conjugated Estrogens—osteoporosis	0.00061	0.000627	CcSEcCtD
Naratriptan—Hypotension—Zoledronate—osteoporosis	0.000609	0.000626	CcSEcCtD
Naratriptan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000609	0.000626	CcSEcCtD
Naratriptan—Dizziness—Raloxifene—osteoporosis	0.000609	0.000625	CcSEcCtD
Naratriptan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000607	0.000624	CcSEcCtD
Naratriptan—Vomiting—Estropipate—osteoporosis	0.000604	0.000621	CcSEcCtD
Naratriptan—Dizziness—Ibandronate—osteoporosis	0.000603	0.000619	CcSEcCtD
Naratriptan—Rash—Estropipate—osteoporosis	0.000599	0.000616	CcSEcCtD
Naratriptan—Dermatitis—Estropipate—osteoporosis	0.000599	0.000615	CcSEcCtD
Naratriptan—Urticaria—Risedronate—osteoporosis	0.000597	0.000613	CcSEcCtD
Naratriptan—Headache—Estropipate—osteoporosis	0.000595	0.000612	CcSEcCtD
Naratriptan—Vomiting—Alendronate—osteoporosis	0.000595	0.000611	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000594	0.00061	CcSEcCtD
Naratriptan—Body temperature increased—Risedronate—osteoporosis	0.000594	0.00061	CcSEcCtD
Naratriptan—Muscle spasms—Estradiol—osteoporosis	0.000592	0.000608	CcSEcCtD
Naratriptan—Rash—Alendronate—osteoporosis	0.00059	0.000606	CcSEcCtD
Naratriptan—Dermatitis—Alendronate—osteoporosis	0.00059	0.000606	CcSEcCtD
Naratriptan—Feeling abnormal—Pamidronate—osteoporosis	0.000588	0.000604	CcSEcCtD
Naratriptan—Hypotension—Conjugated Estrogens—osteoporosis	0.000587	0.000603	CcSEcCtD
Naratriptan—Headache—Alendronate—osteoporosis	0.000586	0.000602	CcSEcCtD
Naratriptan—Paraesthesia—Zoledronate—osteoporosis	0.000586	0.000602	CcSEcCtD
Naratriptan—Vomiting—Raloxifene—osteoporosis	0.000585	0.000601	CcSEcCtD
Naratriptan—Dyspnoea—Zoledronate—osteoporosis	0.000581	0.000597	CcSEcCtD
Naratriptan—Rash—Raloxifene—osteoporosis	0.000581	0.000596	CcSEcCtD
Naratriptan—Dermatitis—Raloxifene—osteoporosis	0.00058	0.000596	CcSEcCtD
Naratriptan—Somnolence—Zoledronate—osteoporosis	0.00058	0.000596	CcSEcCtD
Naratriptan—Vomiting—Ibandronate—osteoporosis	0.00058	0.000595	CcSEcCtD
Naratriptan—Tremor—Estradiol—osteoporosis	0.000577	0.000593	CcSEcCtD
Naratriptan—Headache—Raloxifene—osteoporosis	0.000577	0.000592	CcSEcCtD
Naratriptan—Rash—Ibandronate—osteoporosis	0.000575	0.00059	CcSEcCtD
Naratriptan—Dermatitis—Ibandronate—osteoporosis	0.000574	0.00059	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000572	0.000588	CcSEcCtD
Naratriptan—Ill-defined disorder—Estradiol—osteoporosis	0.000571	0.000587	CcSEcCtD
Naratriptan—Headache—Ibandronate—osteoporosis	0.000571	0.000586	CcSEcCtD
Naratriptan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000568	0.000583	CcSEcCtD
Naratriptan—Vomiting—Calcitriol—osteoporosis	0.000567	0.000583	CcSEcCtD
Naratriptan—Agitation—Estradiol—osteoporosis	0.000566	0.000581	CcSEcCtD
Naratriptan—Nausea—Estropipate—osteoporosis	0.000565	0.00058	CcSEcCtD
Naratriptan—Body temperature increased—Pamidronate—osteoporosis	0.000564	0.00058	CcSEcCtD
Naratriptan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000564	0.000579	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000563	0.000578	CcSEcCtD
Naratriptan—Rash—Calcitriol—osteoporosis	0.000563	0.000578	CcSEcCtD
Naratriptan—Fatigue—Zoledronate—osteoporosis	0.000562	0.000578	CcSEcCtD
Naratriptan—Dermatitis—Calcitriol—osteoporosis	0.000562	0.000577	CcSEcCtD
Naratriptan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00056	0.000575	CcSEcCtD
Naratriptan—Headache—Calcitriol—osteoporosis	0.000559	0.000574	CcSEcCtD
Naratriptan—Somnolence—Conjugated Estrogens—osteoporosis	0.000558	0.000573	CcSEcCtD
Naratriptan—Pain—Zoledronate—osteoporosis	0.000558	0.000573	CcSEcCtD
Naratriptan—Constipation—Zoledronate—osteoporosis	0.000558	0.000573	CcSEcCtD
Naratriptan—Nausea—Alendronate—osteoporosis	0.000556	0.000571	CcSEcCtD
Naratriptan—Malaise—Estradiol—osteoporosis	0.000555	0.00057	CcSEcCtD
Naratriptan—Hypersensitivity—Risedronate—osteoporosis	0.000553	0.000568	CcSEcCtD
Naratriptan—Vertigo—Estradiol—osteoporosis	0.000553	0.000568	CcSEcCtD
Naratriptan—Asthenia—Ethinyl Estradiol—osteoporosis	0.000553	0.000568	CcSEcCtD
Naratriptan—Syncope—Estradiol—osteoporosis	0.000552	0.000567	CcSEcCtD
Naratriptan—Nausea—Raloxifene—osteoporosis	0.000547	0.000562	CcSEcCtD
Naratriptan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000545	0.00056	CcSEcCtD
Naratriptan—Palpitations—Estradiol—osteoporosis	0.000544	0.000559	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000542	0.000557	CcSEcCtD
Naratriptan—Fatigue—Conjugated Estrogens—osteoporosis	0.000541	0.000556	CcSEcCtD
Naratriptan—Nausea—Ibandronate—osteoporosis	0.000541	0.000556	CcSEcCtD
Naratriptan—Loss of consciousness—Estradiol—osteoporosis	0.000541	0.000556	CcSEcCtD
Naratriptan—Asthenia—Risedronate—osteoporosis	0.000539	0.000554	CcSEcCtD
Naratriptan—Feeling abnormal—Zoledronate—osteoporosis	0.000537	0.000552	CcSEcCtD
Naratriptan—Cough—Estradiol—osteoporosis	0.000537	0.000552	CcSEcCtD
Naratriptan—Pain—Conjugated Estrogens—osteoporosis	0.000537	0.000552	CcSEcCtD
Naratriptan—Constipation—Conjugated Estrogens—osteoporosis	0.000537	0.000552	CcSEcCtD
Naratriptan—Pruritus—Risedronate—osteoporosis	0.000531	0.000546	CcSEcCtD
Naratriptan—Nausea—Calcitriol—osteoporosis	0.00053	0.000544	CcSEcCtD
Naratriptan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000527	0.000541	CcSEcCtD
Naratriptan—Hypersensitivity—Pamidronate—osteoporosis	0.000526	0.00054	CcSEcCtD
Naratriptan—Arthralgia—Estradiol—osteoporosis	0.000524	0.000539	CcSEcCtD
Naratriptan—Myalgia—Estradiol—osteoporosis	0.000524	0.000539	CcSEcCtD
Naratriptan—Anxiety—Estradiol—osteoporosis	0.000523	0.000537	CcSEcCtD
Naratriptan—Urticaria—Zoledronate—osteoporosis	0.000518	0.000532	CcSEcCtD
Naratriptan—Discomfort—Estradiol—osteoporosis	0.000518	0.000532	CcSEcCtD
Naratriptan—Body temperature increased—Zoledronate—osteoporosis	0.000516	0.00053	CcSEcCtD
Naratriptan—Diarrhoea—Risedronate—osteoporosis	0.000514	0.000528	CcSEcCtD
Naratriptan—Dry mouth—Estradiol—osteoporosis	0.000513	0.000527	CcSEcCtD
Naratriptan—Asthenia—Pamidronate—osteoporosis	0.000512	0.000526	CcSEcCtD
Naratriptan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000509	0.000523	CcSEcCtD
Naratriptan—Confusional state—Estradiol—osteoporosis	0.000507	0.000521	CcSEcCtD
Naratriptan—Pruritus—Pamidronate—osteoporosis	0.000505	0.000519	CcSEcCtD
Naratriptan—Anaphylactic shock—Estradiol—osteoporosis	0.000503	0.000516	CcSEcCtD
Naratriptan—Oedema—Estradiol—osteoporosis	0.000503	0.000516	CcSEcCtD
Naratriptan—Infection—Estradiol—osteoporosis	0.000499	0.000513	CcSEcCtD
Naratriptan—Urticaria—Conjugated Estrogens—osteoporosis	0.000499	0.000512	CcSEcCtD
Naratriptan—Dizziness—Risedronate—osteoporosis	0.000497	0.00051	CcSEcCtD
Naratriptan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000496	0.00051	CcSEcCtD
Naratriptan—Shock—Estradiol—osteoporosis	0.000495	0.000508	CcSEcCtD
Naratriptan—Nervous system disorder—Estradiol—osteoporosis	0.000493	0.000506	CcSEcCtD
Naratriptan—Vomiting—Ethinyl Estradiol—osteoporosis	0.00049	0.000503	CcSEcCtD
Naratriptan—Diarrhoea—Pamidronate—osteoporosis	0.000489	0.000502	CcSEcCtD
Naratriptan—Skin disorder—Estradiol—osteoporosis	0.000488	0.000501	CcSEcCtD
Naratriptan—Hyperhidrosis—Estradiol—osteoporosis	0.000486	0.000499	CcSEcCtD
Naratriptan—Rash—Ethinyl Estradiol—osteoporosis	0.000486	0.000499	CcSEcCtD
Naratriptan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000485	0.000498	CcSEcCtD
Naratriptan—Headache—Ethinyl Estradiol—osteoporosis	0.000483	0.000496	CcSEcCtD
Naratriptan—Hypersensitivity—Zoledronate—osteoporosis	0.000481	0.000494	CcSEcCtD
Naratriptan—Vomiting—Risedronate—osteoporosis	0.000478	0.000491	CcSEcCtD
Naratriptan—Rash—Risedronate—osteoporosis	0.000474	0.000486	CcSEcCtD
Naratriptan—Dermatitis—Risedronate—osteoporosis	0.000473	0.000486	CcSEcCtD
Naratriptan—Dizziness—Pamidronate—osteoporosis	0.000472	0.000485	CcSEcCtD
Naratriptan—Headache—Risedronate—osteoporosis	0.000471	0.000483	CcSEcCtD
Naratriptan—Asthenia—Zoledronate—osteoporosis	0.000468	0.000481	CcSEcCtD
Naratriptan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000463	0.000475	CcSEcCtD
Naratriptan—Pruritus—Zoledronate—osteoporosis	0.000461	0.000474	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000458	0.00047	CcSEcCtD
Naratriptan—Nausea—Ethinyl Estradiol—osteoporosis	0.000458	0.00047	CcSEcCtD
Naratriptan—Vomiting—Pamidronate—osteoporosis	0.000454	0.000466	CcSEcCtD
Naratriptan—Paraesthesia—Estradiol—osteoporosis	0.000451	0.000464	CcSEcCtD
Naratriptan—Asthenia—Conjugated Estrogens—osteoporosis	0.000451	0.000463	CcSEcCtD
Naratriptan—Rash—Pamidronate—osteoporosis	0.00045	0.000462	CcSEcCtD
Naratriptan—Dermatitis—Pamidronate—osteoporosis	0.00045	0.000462	CcSEcCtD
Naratriptan—Dyspnoea—Estradiol—osteoporosis	0.000448	0.00046	CcSEcCtD
Naratriptan—Headache—Pamidronate—osteoporosis	0.000447	0.000459	CcSEcCtD
Naratriptan—Somnolence—Estradiol—osteoporosis	0.000447	0.000459	CcSEcCtD
Naratriptan—Diarrhoea—Zoledronate—osteoporosis	0.000446	0.000458	CcSEcCtD
Naratriptan—Nausea—Risedronate—osteoporosis	0.000446	0.000458	CcSEcCtD
Naratriptan—Pruritus—Conjugated Estrogens—osteoporosis	0.000444	0.000456	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Estradiol—osteoporosis	0.000434	0.000446	CcSEcCtD
Naratriptan—Fatigue—Estradiol—osteoporosis	0.000433	0.000445	CcSEcCtD
Naratriptan—Dizziness—Zoledronate—osteoporosis	0.000431	0.000443	CcSEcCtD
Naratriptan—Pain—Estradiol—osteoporosis	0.00043	0.000441	CcSEcCtD
Naratriptan—Constipation—Estradiol—osteoporosis	0.00043	0.000441	CcSEcCtD
Naratriptan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00043	0.000441	CcSEcCtD
Naratriptan—Nausea—Pamidronate—osteoporosis	0.000424	0.000436	CcSEcCtD
Naratriptan—Dizziness—Conjugated Estrogens—osteoporosis	0.000415	0.000427	CcSEcCtD
Naratriptan—Vomiting—Zoledronate—osteoporosis	0.000415	0.000426	CcSEcCtD
Naratriptan—Feeling abnormal—Estradiol—osteoporosis	0.000414	0.000425	CcSEcCtD
Naratriptan—Rash—Zoledronate—osteoporosis	0.000411	0.000422	CcSEcCtD
Naratriptan—Dermatitis—Zoledronate—osteoporosis	0.000411	0.000422	CcSEcCtD
Naratriptan—Headache—Zoledronate—osteoporosis	0.000409	0.00042	CcSEcCtD
Naratriptan—Vomiting—Conjugated Estrogens—osteoporosis	0.000399	0.00041	CcSEcCtD
Naratriptan—Urticaria—Estradiol—osteoporosis	0.000399	0.00041	CcSEcCtD
Naratriptan—Body temperature increased—Estradiol—osteoporosis	0.000397	0.000408	CcSEcCtD
Naratriptan—Rash—Conjugated Estrogens—osteoporosis	0.000396	0.000407	CcSEcCtD
Naratriptan—Dermatitis—Conjugated Estrogens—osteoporosis	0.000396	0.000406	CcSEcCtD
Naratriptan—Headache—Conjugated Estrogens—osteoporosis	0.000393	0.000404	CcSEcCtD
Naratriptan—Nausea—Zoledronate—osteoporosis	0.000387	0.000398	CcSEcCtD
Naratriptan—Nausea—Conjugated Estrogens—osteoporosis	0.000373	0.000383	CcSEcCtD
Naratriptan—Hypersensitivity—Estradiol—osteoporosis	0.00037	0.00038	CcSEcCtD
Naratriptan—Asthenia—Estradiol—osteoporosis	0.000361	0.00037	CcSEcCtD
Naratriptan—Pruritus—Estradiol—osteoporosis	0.000356	0.000365	CcSEcCtD
Naratriptan—Diarrhoea—Estradiol—osteoporosis	0.000344	0.000353	CcSEcCtD
Naratriptan—Dizziness—Estradiol—osteoporosis	0.000332	0.000341	CcSEcCtD
Naratriptan—Vomiting—Estradiol—osteoporosis	0.00032	0.000328	CcSEcCtD
Naratriptan—Rash—Estradiol—osteoporosis	0.000317	0.000326	CcSEcCtD
Naratriptan—Dermatitis—Estradiol—osteoporosis	0.000317	0.000325	CcSEcCtD
Naratriptan—Headache—Estradiol—osteoporosis	0.000315	0.000323	CcSEcCtD
Naratriptan—Nausea—Estradiol—osteoporosis	0.000299	0.000307	CcSEcCtD
Naratriptan—HTR1A—GPCR downstream signaling—PTH1R—osteoporosis	0.000108	0.00409	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000106	0.004	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CNR2—osteoporosis	0.000105	0.00399	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—MGLL—osteoporosis	0.000105	0.00396	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—MGLL—osteoporosis	0.000102	0.00387	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000101	0.00382	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—PTH—osteoporosis	0.000101	0.0038	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—WNT1—osteoporosis	9.91e-05	0.00375	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PTHLH—osteoporosis	9.87e-05	0.00373	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CALCA—osteoporosis	9.83e-05	0.00372	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CALCR—osteoporosis	9.82e-05	0.00372	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PTH1R—osteoporosis	9.82e-05	0.00372	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CNR2—osteoporosis	9.79e-05	0.00371	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MGLL—osteoporosis	9.66e-05	0.00366	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CALCA—osteoporosis	9.62e-05	0.00364	CbGpPWpGaD
Naratriptan—MAOA—Biological oxidations—POMC—osteoporosis	9.57e-05	0.00362	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LRP5—osteoporosis	9.43e-05	0.00357	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—WNT1—osteoporosis	9.21e-05	0.00348	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PKM—osteoporosis	9.02e-05	0.00341	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—FDPS—osteoporosis	9.02e-05	0.00341	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LRP6—osteoporosis	9.02e-05	0.00341	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PTHLH—osteoporosis	8.96e-05	0.00339	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—ADCY5—osteoporosis	8.83e-05	0.00334	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CALCA—osteoporosis	8.69e-05	0.00329	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—ADCY5—osteoporosis	8.61e-05	0.00326	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SOST—osteoporosis	8.6e-05	0.00325	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—MGLL—osteoporosis	8.59e-05	0.00325	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6R—osteoporosis	8.58e-05	0.00325	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GPD2—osteoporosis	8.55e-05	0.00324	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PGLS—osteoporosis	8.55e-05	0.00324	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—POMC—osteoporosis	8.49e-05	0.00321	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SOST—osteoporosis	8.42e-05	0.00319	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—PTHLH—osteoporosis	8.33e-05	0.00315	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—POMC—osteoporosis	8.32e-05	0.00315	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—POMC—osteoporosis	8.04e-05	0.00304	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CALCA—osteoporosis	7.89e-05	0.00298	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ATIC—osteoporosis	7.82e-05	0.00296	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PNP—osteoporosis	7.82e-05	0.00296	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MGLL—osteoporosis	7.8e-05	0.00295	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTH1R—osteoporosis	7.78e-05	0.00294	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALCR—osteoporosis	7.78e-05	0.00294	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL1B—osteoporosis	7.68e-05	0.0029	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TLN1—osteoporosis	7.61e-05	0.00288	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PTH—osteoporosis	7.61e-05	0.00288	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTH1R—osteoporosis	7.61e-05	0.00288	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALCR—osteoporosis	7.61e-05	0.00288	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PTH—osteoporosis	7.46e-05	0.00282	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CNR2—osteoporosis	7.42e-05	0.00281	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CALCA—osteoporosis	7.33e-05	0.00277	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CNR2—osteoporosis	7.27e-05	0.00275	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PTH—osteoporosis	6.91e-05	0.00262	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PTH—osteoporosis	6.77e-05	0.00256	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.75e-05	0.00256	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CNR2—osteoporosis	6.74e-05	0.00255	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—OXCT1—osteoporosis	6.65e-05	0.00252	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CA2—osteoporosis	6.65e-05	0.00252	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.61e-05	0.0025	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CNR2—osteoporosis	6.6e-05	0.0025	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—P4HB—osteoporosis	6.57e-05	0.00248	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—osteoporosis	6.53e-05	0.00247	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MGLL—osteoporosis	6.48e-05	0.00245	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SOST—osteoporosis	6.41e-05	0.00243	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTH—osteoporosis	6.39e-05	0.00242	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—POMC—osteoporosis	6.34e-05	0.0024	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—WNT1—osteoporosis	6.34e-05	0.0024	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PTHLH—osteoporosis	6.31e-05	0.00239	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RAP1A—osteoporosis	6.28e-05	0.00238	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CNR2—osteoporosis	6.22e-05	0.00236	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—WNT1—osteoporosis	6.2e-05	0.00235	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—ADCY5—osteoporosis	6.18e-05	0.00234	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PTHLH—osteoporosis	6.18e-05	0.00234	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MGLL—osteoporosis	6.18e-05	0.00234	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NFATC1—osteoporosis	6.12e-05	0.00232	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DKK1—osteoporosis	6.08e-05	0.0023	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MGLL—osteoporosis	6.05e-05	0.00229	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LRP5—osteoporosis	6.03e-05	0.00228	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LRP5—osteoporosis	5.9e-05	0.00223	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—WNT1—osteoporosis	5.85e-05	0.00221	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTH1R—osteoporosis	5.8e-05	0.00219	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALCR—osteoporosis	5.8e-05	0.00219	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LRP6—osteoporosis	5.77e-05	0.00218	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PTHLH—osteoporosis	5.73e-05	0.00217	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FGA—osteoporosis	5.69e-05	0.00215	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PTH—osteoporosis	5.68e-05	0.00215	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LRP6—osteoporosis	5.65e-05	0.00214	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—ADCY5—osteoporosis	5.61e-05	0.00212	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PTHLH—osteoporosis	5.61e-05	0.00212	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—osteoporosis	5.57e-05	0.00211	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CALCA—osteoporosis	5.55e-05	0.0021	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CNR2—osteoporosis	5.53e-05	0.00209	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—IDH2—osteoporosis	5.51e-05	0.00209	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CALCA—osteoporosis	5.44e-05	0.00206	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTHLH—osteoporosis	5.29e-05	0.002	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—BMP2—osteoporosis	5.29e-05	0.002	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP27A1—osteoporosis	5.18e-05	0.00196	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FGB—osteoporosis	5.18e-05	0.00196	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PTH—osteoporosis	5.16e-05	0.00195	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—POMC—osteoporosis	5.14e-05	0.00195	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CALCA—osteoporosis	5.04e-05	0.00191	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ACP5—osteoporosis	5.04e-05	0.00191	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.04e-05	0.00191	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—POMC—osteoporosis	5.04e-05	0.00191	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CNR2—osteoporosis	5.03e-05	0.0019	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PSMA5—osteoporosis	5e-05	0.00189	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PSMA2—osteoporosis	5e-05	0.00189	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CALCA—osteoporosis	4.94e-05	0.00187	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TLN1—osteoporosis	4.87e-05	0.00184	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TLN1—osteoporosis	4.77e-05	0.0018	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—osteoporosis	4.73e-05	0.00179	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—WNT1—osteoporosis	4.73e-05	0.00179	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PTHLH—osteoporosis	4.71e-05	0.00178	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TPI1—osteoporosis	4.69e-05	0.00177	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CALCA—osteoporosis	4.66e-05	0.00176	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MGLL—osteoporosis	4.61e-05	0.00174	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—POMC—osteoporosis	4.54e-05	0.00172	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LRP5—osteoporosis	4.5e-05	0.0017	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	4.49e-05	0.0017	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—P4HB—osteoporosis	4.41e-05	0.00167	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GAPDH—osteoporosis	4.33e-05	0.00164	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LRP6—osteoporosis	4.3e-05	0.00163	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PTHLH—osteoporosis	4.27e-05	0.00162	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—KL—osteoporosis	4.23e-05	0.0016	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—RAP1A—osteoporosis	4.21e-05	0.00159	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—P4HB—osteoporosis	4.2e-05	0.00159	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CALCA—osteoporosis	4.14e-05	0.00157	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—POMC—osteoporosis	4.13e-05	0.00156	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—P4HB—osteoporosis	4.11e-05	0.00156	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTH—osteoporosis	4.08e-05	0.00155	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6R—osteoporosis	4.03e-05	0.00152	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RAP1A—osteoporosis	4.01e-05	0.00152	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTH—osteoporosis	4e-05	0.00151	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CNR2—osteoporosis	3.98e-05	0.00151	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADCY5—osteoporosis	3.95e-05	0.0015	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RAP1A—osteoporosis	3.93e-05	0.00149	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NFATC1—osteoporosis	3.92e-05	0.00148	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CNR2—osteoporosis	3.9e-05	0.00147	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DKK1—osteoporosis	3.89e-05	0.00147	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADCY5—osteoporosis	3.87e-05	0.00146	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—POMC—osteoporosis	3.84e-05	0.00145	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NFATC1—osteoporosis	3.83e-05	0.00145	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.82e-05	0.00145	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DKK1—osteoporosis	3.8e-05	0.00144	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CALCA—osteoporosis	3.76e-05	0.00142	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—WNT1—osteoporosis	3.74e-05	0.00142	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—WNT1—osteoporosis	3.66e-05	0.00139	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGA—osteoporosis	3.64e-05	0.00138	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TLN1—osteoporosis	3.63e-05	0.00137	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADCY5—osteoporosis	3.59e-05	0.00136	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGA—osteoporosis	3.56e-05	0.00135	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADCY5—osteoporosis	3.51e-05	0.00133	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ENO1—osteoporosis	3.41e-05	0.00129	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTHLH—osteoporosis	3.38e-05	0.00128	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BMP2—osteoporosis	3.38e-05	0.00128	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PSMA5—osteoporosis	3.36e-05	0.00127	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PSMA2—osteoporosis	3.36e-05	0.00127	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADCY5—osteoporosis	3.31e-05	0.00125	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTHLH—osteoporosis	3.31e-05	0.00125	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BMP2—osteoporosis	3.31e-05	0.00125	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGB—osteoporosis	3.31e-05	0.00125	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGB—osteoporosis	3.24e-05	0.00123	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SPP1—osteoporosis	3.21e-05	0.00121	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PSMA2—osteoporosis	3.2e-05	0.00121	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PSMA5—osteoporosis	3.2e-05	0.00121	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—P4HB—osteoporosis	3.13e-05	0.00119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PSMA2—osteoporosis	3.13e-05	0.00118	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PSMA5—osteoporosis	3.13e-05	0.00118	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTH—osteoporosis	3.05e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RAP1A—osteoporosis	2.99e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALCA—osteoporosis	2.98e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CNR2—osteoporosis	2.97e-05	0.00112	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADCY5—osteoporosis	2.95e-05	0.00112	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NFATC1—osteoporosis	2.92e-05	0.00111	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALCA—osteoporosis	2.92e-05	0.0011	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—POMC—osteoporosis	2.91e-05	0.0011	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IRS2—osteoporosis	2.9e-05	0.0011	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DKK1—osteoporosis	2.9e-05	0.0011	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—POMC—osteoporosis	2.85e-05	0.00108	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LEP—osteoporosis	2.84e-05	0.00107	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—WNT1—osteoporosis	2.79e-05	0.00106	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP19A1—osteoporosis	2.72e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGA—osteoporosis	2.72e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ESR1—osteoporosis	2.71e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KL—osteoporosis	2.71e-05	0.00102	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.68e-05	0.00101	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KL—osteoporosis	2.65e-05	0.001	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—POMC—osteoporosis	2.64e-05	0.000999	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—POMC—osteoporosis	2.58e-05	0.000978	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6R—osteoporosis	2.57e-05	0.000974	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IRS1—osteoporosis	2.53e-05	0.000958	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTHLH—osteoporosis	2.52e-05	0.000955	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BMP2—osteoporosis	2.52e-05	0.000955	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6R—osteoporosis	2.52e-05	0.000954	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGB—osteoporosis	2.47e-05	0.000935	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—POMC—osteoporosis	2.44e-05	0.000923	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PSMA2—osteoporosis	2.39e-05	0.000903	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PSMA5—osteoporosis	2.39e-05	0.000903	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6R—osteoporosis	2.38e-05	0.0009	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1—osteoporosis	2.35e-05	0.000887	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADCY5—osteoporosis	2.22e-05	0.000842	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALCA—osteoporosis	2.22e-05	0.000841	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GPX1—osteoporosis	2.22e-05	0.000839	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—osteoporosis	2.17e-05	0.00082	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADCY5—osteoporosis	2.12e-05	0.000802	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADCY5—osteoporosis	2.08e-05	0.000785	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SPP1—osteoporosis	2.05e-05	0.000776	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—osteoporosis	2.05e-05	0.000774	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KL—osteoporosis	2.02e-05	0.000764	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SPP1—osteoporosis	2.01e-05	0.00076	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.97e-05	0.000745	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.92e-05	0.000727	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IRS2—osteoporosis	1.85e-05	0.000702	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.82e-05	0.000687	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LEP—osteoporosis	1.81e-05	0.000687	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—osteoporosis	1.79e-05	0.000679	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LEP—osteoporosis	1.78e-05	0.000672	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.73e-05	0.000656	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.7e-05	0.000642	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—osteoporosis	1.64e-05	0.000619	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.62e-05	0.000613	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.59e-05	0.0006	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.58e-05	0.000598	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—osteoporosis	1.56e-05	0.00059	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.53e-05	0.000579	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—osteoporosis	1.53e-05	0.000578	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.52e-05	0.000576	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.5e-05	0.000567	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.49e-05	0.000564	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.47e-05	0.000556	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—osteoporosis	1.41e-05	0.000533	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.41e-05	0.000532	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.38e-05	0.000523	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LEP—osteoporosis	1.35e-05	0.000512	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.29e-05	0.000489	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.21e-05	0.000457	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—osteoporosis	1.16e-05	0.00044	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.15e-05	0.000434	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.13e-05	0.000429	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.12e-05	0.000425	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.12e-05	0.000423	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—osteoporosis	1.06e-05	0.000401	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—osteoporosis	9.01e-06	0.000341	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—osteoporosis	8.99e-06	0.00034	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—osteoporosis	8.82e-06	0.000334	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—osteoporosis	8.8e-06	0.000333	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—osteoporosis	8.55e-06	0.000324	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—osteoporosis	6.77e-06	0.000256	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—osteoporosis	6.72e-06	0.000254	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—osteoporosis	6.71e-06	0.000254	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—osteoporosis	6.63e-06	0.000251	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—osteoporosis	5.05e-06	0.000191	CbGpPWpGaD
